| BUSINESS INFORMATION | Separately, Syngenta's biopharma unit has entered a drug development agreement with Fulcrum Pharma. Syngenta aims to move its lead projects toward clinical development by implementing document-driven tools and processes from Fulcrum |
|
Want more information ? Interested in the hidden information ? Click here and do your request. |